Meet Our Editorial Board Member
Author:
Affiliation:
1. Medical University of Lodz, Cio kowskiego, Lodz, Poland
Publisher
Bentham Science Publishers Ltd.
Subject
Pharmacology,Molecular Medicine,Drug Discovery,Biochemistry,Organic Chemistry
Reference8 articles.
1. Robak P.; Dróżdż I.; Jarych D.; Mikulski D.; Węgłowska E.; Siemieniuk-Ryś M.; Misiewicz M.; Stawiski K.; Fendler W.; Szemraj J.; Smolewski P.; Robak T.; The value of serum MicroRNA expression signature in predicting refractoriness to bortezomib-based therapy in multiple myeloma patients. Cancers (Basel) 2020,12(9),2569
2. Robak T.; Kaźmierczak M.; Jarque I.; Musteata V.; Treliński J.; Cooper N.; Kiessling P.; Massow U.; Woltering F.; Snipes R.; Ke J.; Langdon G.; Bussel J.B.; Jolles S.; Phase 2 multiple-dose study of an FcRn inhibitor, rozanolixizumab, in patients with primary immune thrombocytopenia. Blood Adv 2020,4(17),4136-4146
3. Robak P.; Węgłowska E.; Dróżdż I.; Mikulski D.; Jarych D.; Ferlińska M.; Wawrzyniak E.; Misiewicz M.; Smolewski P.; Fendler W.; Szemraj J.; Robak T.; Cytokine and chemokine profile in patients with multiple myeloma treated with bortezomib. Mediat Inflamm 2020,2020
4. Gdynia G.; Robak T.; Kopitz J.; Heller A.; Grekova S.; Duglova K.; Laukemper G.; Heinzel-Gutenbrunner M.; Gutenbrunner C.; Roth W.; Ho A.D.; Schirmacher P.; Shmitt M.; Dreger P.; Sellner L.; Distinct activities of glycolytic enzymes identify chronic lymphocytic leukemia patients with a more aggressive course and resistance to chemo-immunotherapy. E Biol Med 2018,32,125-133
5. Robak T.; Huang H.; Jin J.; Zhu J.; Liu T.; Samoilova O.; Pylypenko H.; Verhoef G.; Siritanaratkul N.; Osmanov E.; Alexeeva J.; Pereira J.; Drach J.; Mayer J.; Hong X.; Okamoto R.; Pei L.; Rooney B.; van de Velde H.; Cavalli F.; Bortezomib-based therapy for newly diagnosed mantle-cell lymphoma. N Engl J Med 2015,372(10),944-953
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3